These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus. Jacqueline C, Amador G, Batard E, Le Mabecque V, Miègeville AF, Biek D, Caillon J, Potel G. J Antimicrob Chemother; 2011 Apr; 66(4):863-6. PubMed ID: 21393213 [Abstract] [Full Text] [Related]
3. Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report. Duss FR, Garcia de la Mària C, Croxatto A, Giulieri S, Lamoth F, Manuel O, Miró JM. J Antimicrob Chemother; 2019 Sep 01; 74(9):2626-2630. PubMed ID: 31298264 [Abstract] [Full Text] [Related]
7. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Miró JM, Entenza JM, Del Río A, Velasco M, Castañeda X, Garcia de la Mària C, Giddey M, Armero Y, Pericàs JM, Cervera C, Mestres CA, Almela M, Falces C, Marco F, Moreillon P, Moreno A, Hospital Clinic Experimental Endocarditis Study Group. Antimicrob Agents Chemother; 2012 Aug 01; 56(8):4511-5. PubMed ID: 22644033 [Abstract] [Full Text] [Related]
8. Ceftaroline for the treatment of prosthetic valve endocarditis due to methicillin-resistant Staphylococcus aureus. Pagani L, Bonnin P, Janssen C, Desjoyaux E, Vitrat V, Bru JP. J Heart Valve Dis; 2014 Mar 01; 23(2):219-21. PubMed ID: 25076554 [Abstract] [Full Text] [Related]
9. A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli. Morrisette T, Lagnf AM, Alosaimy S, Rybak MJ. Eur J Clin Microbiol Infect Dis; 2020 Nov 01; 39(11):2199-2203. PubMed ID: 32535805 [Abstract] [Full Text] [Related]
10. Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA). Galani L, Pefanis A, Sakka V, Iliopoulos D, Donta I, Triantafyllidi H, Skiadas I, Karayiannakos P, Giamarellou H. Int J Antimicrob Agents; 2009 Jan 01; 33(1):65-9. PubMed ID: 18818055 [Abstract] [Full Text] [Related]